BVD Eradication and Cattle Welfare: How PI Removal Improves Herd Health

Bovine Viral Diarrhea eradication programs that identify and remove persistently infected cattle dramatically reduce disease burden and welfare costs across entire cattle populations.

Key Facts

Persistently infected cattle shed BVD virus continuously, maintaining infection pressure on entire herds
PI cattle have poor welfare outcomes including immunosuppression, poor growth, and high disease susceptibility
Ear notch or blood testing can identify PIs from birth, enabling rapid removal before significant viral spread
Scotland became provisionally BVD-free through national eradication demonstrating the feasibility of elimination
Non-PI cattle in BVD-positive herds have compromised immune function affecting their disease susceptibility and welfare
Biosecurity for purchased cattle is critical as a single PI introduction can re-infect a cleared herd
Economic analysis consistently shows eradication programs have positive return on investment from reduced disease costs

Welfare Considerations

BVD eradication is exemplary welfare policy: systematically identifying and removing animals whose existence causes chronic suffering to themselves while propagating disease that reduces the welfare of every other animal in the herd. PI cattle experience a life of chronic immune suppression and disease susceptibility that represents genuinely poor welfare. The eradication approach eliminates this category of welfare harm while reducing the disease burden on all other animals in the population. The national eradication model demonstrated in Scotland shows that complete elimination is achievable, not just reduction - and the welfare and economic benefits of a BVD-free national herd are substantial and permanent.

What You Can Do

Test all new-born calves in herds with BVD problems and remove PIs promptly under veterinary guidance
Implement strict biosecurity for purchased cattle including health status documentation and quarantine protocols
Participate in national or regional BVD eradication programs through testing and reporting requirements
Vaccinate against BVD as part of a comprehensive eradication strategy rather than as a standalone control measure
Support policy advocacy for national BVD eradication programs in countries that have not yet implemented them